Photo from wikipedia
Ultra‐rapid lispro (URLi) is a novel ultra‐rapid mealtime insulin. This study compared the pharmacokinetic and glucodynamic profiles, safety, and tolerability of URLi and lispro (Humalog®) in Japanese patients with type… Click to show full abstract
Ultra‐rapid lispro (URLi) is a novel ultra‐rapid mealtime insulin. This study compared the pharmacokinetic and glucodynamic profiles, safety, and tolerability of URLi and lispro (Humalog®) in Japanese patients with type 1 diabetes mellitus.
Keywords:
ultra rapid;
patients type;
humalog japanese;
japanese patients;
rapid lispro;
type diabetes
Journal Title: Journal of Diabetes Investigation
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Diabetes Investigation
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!